Detail page

Knowledge Web

Person

Philipp Erben (1973-)

Arzt

Name	Philipp Erben
Time	1973- (Date of birth and death)
Place	Deutschland
Academic degree	Dr. med.
Profession	Arzt (characteristic profession)
Variant	Philipp Franz Wilhelm Erben P. Erben
Further information	Diss. Fakultät für Klinische Medizin; früher: Assistenzarzt und wissenschaftlicher Mitarbeiter in der III. Medizinischen Klinik der Medizinischen Fakultät Mannheim der Universität Heidelberg; jetzt: Leiter des Forschungslabors der Urologischen Klinik der Medizinischen Fakultät Mannheim der Universität Heidelberg
Record type	Person
GND-Identifier	128501014
Record ID	128501014
Involved in show all Humane endogene Retroviren im Urothelkarzinom – Expressionsanalysen in malignen und benignen Blasenzelllinien Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial) A genome-wide association study with tissue transcriptomics identifies genetic drivers for classic bladder exstrophy Upper Tract Urinary Cancer Recurrence after Radical Cystectomy: Risk Assessment of Intraoperative Frozen Section Etablierte und neue Risikofaktoren für perioperative Komplikationen nach offener radikaler Zystektomie Die ErbB-Rezeptorfamilie und ihre Spleißvarianten im muskelinvasiven Urothelkarzinom der Harnblase : eine retrospektive molekulare Analyse Die vesikourethrale Anastomosenstenose nach radikaler Prostatektomie : molekulare Analysen eines chronischen Prozesses Extracellular matrix in muscle-invasive bladder cancer: Identification and validation of ECM related mechanisms in MIBC: A multi-omics analysis of a novel interpreted 3D in vitro model Extrazelluläre Vesikel als Mediatoren invasions- und metastasierungsfördernder Prozesse im Urothelkarzinom der Harnblase : funktionelle, Expressions- und Überlebensanalysen Frailty-Indikatoren als prädiktive Marker für die postoperative Morbidität und Mortalität nach radikaler Zystektomie High Androgen Receptor mRNA Expression Is Associated with Improved Outcome in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer Patients KRT20, KRT5, ESR1 and ERBB2 Expression Can Predict Pathologic Outcome in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer Molekulare Charakterisierung der 17q12-21, 7p11.2 und 8q22.2 Regionen und deren prognostische Assoziationen im muskelinvasiven Harnblasenkarzinom Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancer Molekulare Subtypen des Urothelkarzinoms der Harnblase – Hintergründe und klinische Relevanz Subtype specific expression and survival prediction of pivotal lncRNAs in muscle invasive bladder cancer B-MYB—p53-related relevant regulator for the progression of clear cell renal cell carcinoma ANLN, TLE2 and MIR31HG transcripts in muscle invasive bladder cancer: a functional and clinical analysis based on molecular subtypes Genexpression molekularer Zielstrukturen im gepaarten Primärtumor, invasiven Tumor und Metastase beim Harnblasenkarzinom Relevanz perioperativer Einflussfaktoren auf das onkologische Outcome bei Patienten mit Urothelkarzinom der oberen Harnwege ANLN and TLE2 in Muscle Invasive Bladder Cancer: A Functional and Clinical Evaluation Based on In Silico and In Vitro Data Lymphangiogenese- und Proliferationsmarker: Assoziation mit histopathologischen Merkmalen und Krankheitsverlauf beim Harnblasenkarzinom nach radikaler Zystektomie Analysis of the prognostic relevance of sex-steroid hormonal receptor mRNA expression in muscle-invasive urothelial carcinoma of the urinary bladder CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making FOXM1 predicts disease progression in non-muscle invasive bladder cancer Cell-Free DNA and Neuromediators in Detecting Aggressive Variant Prostate Cancer Funktionelle Charakterisierung neuer Genkandidaten exosomaler Proteine im Prostatakarzinom Gene mit regulatorischer Funktion für die exosomale Sekretion: Welche Rolle spielen sie im Prostatakarzinom? Her2/neu-Genexpression auf mRNA-Ebene im muskelinvasiven Urothelkarzinom: prognostische Rolle und Validität mRNA-Expression of KRT5 and KRT20 Defines Distinct Prognostic Subgroups of Muscle-Invasive Urothelial Bladder Cancer Correlating with Histological Variants High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patients The EEF1A2 gene expression as risk predictor in localized prostate cancer In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival Impact of Altered WNT2B Expression on Bladder Wall Fibroblasts: Implications for Apoptosis Regulation in the Stroma of the Lower Urinary Tract ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ ESR1, ERBB2, and Ki67 mRNA expression predicts stage and grade of non-muscle-invasive bladder carcinoma (NMIBC) Complete and Durable Remission of Human Epidermal Growth Factor Receptor 2-Positive Metastatic Urothelial Carcinoma Following Third-Line Treatment with Trastuzumab and Gemcitabine Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib Molecular Analysis of Desmoid Tumors with a High-Density Single-Nucleotide Polymorphism Array Identifies New Molecular Candidate Lesions Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy Annexin and Survivin in Locally Advanced Rectal Cancer: Indicators of Resistance to Preoperative Chemoradiotherapy? Akustische Energie zur Transfektion beim Prostatakarzinom : Entwicklung und Evaluation

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Philipp Erben (1973-)

Humane endogene Retroviren im Urothelkarzinom – Expressionsanalysen in malignen und benignen Blasenzelllinien

Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial)

A genome-wide association study with tissue transcriptomics identifies genetic drivers for classic bladder exstrophy

Upper Tract Urinary Cancer Recurrence after Radical Cystectomy: Risk Assessment of Intraoperative Frozen Section

Etablierte und neue Risikofaktoren für perioperative Komplikationen nach offener radikaler Zystektomie

Die ErbB-Rezeptorfamilie und ihre Spleißvarianten im muskelinvasiven Urothelkarzinom der Harnblase : eine retrospektive molekulare Analyse

Die vesikourethrale Anastomosenstenose nach radikaler Prostatektomie : molekulare Analysen eines chronischen Prozesses

Extracellular matrix in muscle-invasive bladder cancer: Identification and validation of ECM related mechanisms in MIBC: A multi-omics analysis of a novel interpreted 3D in vitro model

Extrazelluläre Vesikel als Mediatoren invasions- und metastasierungsfördernder Prozesse im Urothelkarzinom der Harnblase : funktionelle, Expressions- und Überlebensanalysen

Frailty-Indikatoren als prädiktive Marker für die postoperative Morbidität und Mortalität nach radikaler Zystektomie

High Androgen Receptor mRNA Expression Is Associated with Improved Outcome in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer

Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer Patients

KRT20, KRT5, ESR1 and ERBB2 Expression Can Predict Pathologic Outcome in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer

Molekulare Charakterisierung der 17q12-21, 7p11.2 und 8q22.2 Regionen und deren prognostische Assoziationen im muskelinvasiven Harnblasenkarzinom

Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancer

Molekulare Subtypen des Urothelkarzinoms der Harnblase – Hintergründe und klinische Relevanz

Subtype specific expression and survival prediction of pivotal lncRNAs in muscle invasive bladder cancer

B-MYB—p53-related relevant regulator for the progression of clear cell renal cell carcinoma

ANLN, TLE2 and MIR31HG transcripts in muscle invasive bladder cancer: a functional and clinical analysis based on molecular subtypes

Genexpression molekularer Zielstrukturen im gepaarten Primärtumor, invasiven Tumor und Metastase beim Harnblasenkarzinom

Relevanz perioperativer Einflussfaktoren auf das onkologische Outcome bei Patienten mit Urothelkarzinom der oberen Harnwege

ANLN and TLE2 in Muscle Invasive Bladder Cancer: A Functional and Clinical Evaluation Based on In Silico and In Vitro Data

Lymphangiogenese- und Proliferationsmarker: Assoziation mit histopathologischen Merkmalen und Krankheitsverlauf beim Harnblasenkarzinom nach radikaler Zystektomie

Analysis of the prognostic relevance of sex-steroid hormonal receptor mRNA expression in muscle-invasive urothelial carcinoma of the urinary bladder

CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making

FOXM1 predicts disease progression in non-muscle invasive bladder cancer

Cell-Free DNA and Neuromediators in Detecting Aggressive Variant Prostate Cancer

Funktionelle Charakterisierung neuer Genkandidaten exosomaler Proteine im Prostatakarzinom

Gene mit regulatorischer Funktion für die exosomale Sekretion: Welche Rolle spielen sie im Prostatakarzinom?

Her2/neu-Genexpression auf mRNA-Ebene im muskelinvasiven Urothelkarzinom: prognostische Rolle und Validität

mRNA-Expression of KRT5 and KRT20 Defines Distinct Prognostic Subgroups of Muscle-Invasive Urothelial Bladder Cancer Correlating with Histological Variants

High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patients

The EEF1A2 gene expression as risk predictor in localized prostate cancer

In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival

Impact of Altered WNT2B Expression on Bladder Wall Fibroblasts: Implications for Apoptosis Regulation in the Stroma of the Lower Urinary Tract

ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ

ESR1, ERBB2, and Ki67 mRNA expression predicts stage and grade of non-muscle-invasive bladder carcinoma (NMIBC)

Complete and Durable Remission of Human Epidermal Growth Factor Receptor 2-Positive Metastatic Urothelial Carcinoma Following Third-Line Treatment with Trastuzumab and Gemcitabine

Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib

Molecular Analysis of Desmoid Tumors with a High-Density Single-Nucleotide Polymorphism Array Identifies New Molecular Candidate Lesions

Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy

Annexin and Survivin in Locally Advanced Rectal Cancer: Indicators of Resistance to Preoperative Chemoradiotherapy?

Akustische Energie zur Transfektion beim Prostatakarzinom : Entwicklung und Evaluation